
The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.

Cannabis and Dementia Symptoms: Healer Webinar Examines Relevant Research

Nebraska Approaches Deadline to Include Medical Cannabis on November Ballot

The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.

Kentucky Governor signs HB 829, and introduces lottery for dispensary applications.

As we celebrate the 4/20 holiday, here is a selection of medical cannabis coverage we have explored in the cannabis industry this year so far.

Keynote speaker Jamila Owens-Todd shares her perspectives on cannabis from medical and science viewpoints.

One step forward, two steps back: updates on cannabis legal movements in three different states.

After stalled attempts over the years, a bill that would create a medical cannabis program in the Sunflower State has made an appearance.

Clinically significant reductions in symptoms were reported.

Join us for the final installment of this multipart interview series as the co-founders of Cannabis Patients Pacific Northwest share how they envision the future of cannabis regulations.

A ballot initiative to expand medical cannabis access in Arkansas has been resubmitted.

Results highlighted the complexities of cannabis use and products among cancer survivors.

Join us for Part VI of this multipart interview series as the co-founders of Cannabis Patients Pacific Northwest describe the topics covered in their cannabis education, both inside and outside the classroom.

Bills placed before the South Dakota Senate Health and Human Services Committee proposed changes to the state’s medical cannabis program.

A new bill to define cannabis flower as an accepted form of medical cannabis recently advanced through a subcommittee.

A recently published observational study examined the risks of medical cannabis for developing various heart conditions.

Join us for Part V of this multipart interview series as the co-founders of Cannabis Patients Pacific Northwest share their experiences navigating state and federal regulations around medical cannabis.

Join us for Part IV of this multipart interview series where we dive into the complexities of state cannabis grow laws with the non-profit, Cannabis Patients Pacific Northwest.

Despite widespread legalization in the US, many legal cannabis operators can still be subjected to raids and government interference. In 2021, when we first met Jason Hanley, owner of CARE Waialua, he shared his passion for helping patients on his medical cannabis farm on Oahu, Hawaii and explained the rules and operation there. Recently, his farm was raided by the federal government reportedly for no stated reason, and he has yet to be charged with any crime or citation. Here, Hanley shares his story of what transpired, how it has impacted his farm and the patients he serves, and what he hopes to see change in the future.

Join us for part III of this multipart interview series as we go in-depth into the accomplishments and goals of the non-profit, Cannabis Patients Pacific Northwest.

Virginia residents are traveling farther for their medical cannabis due to high pricing.

Join us for part II of this multipart interview series as we go in-depth into the accomplishments and goals of the non-profit, Cannabis Patients Pacific Northwest.

The Senate recently passed a bill that would enable veterans to discuss and be recommended medical cannabis by Veterans Affairs doctors.

Ukraine may legalize medical cannabis this month for the benefit of millions of citizens.

Missouri will transfer $17 million from its cannabis programs to the Missouri Veterans Commission to support veterans' health care and services, following the success of both medical and adult-use cannabis programs in the state.

Ireland opens up their first medical cannabis clinic.

The University of Buffalo has received a grant from the NIH National Cancer Institute to research cannabis’s medicinal effect on cancer immunotherapy treatment.